Health Care/Hospital

Trip.com Group Expands Cancellation Guarantee To Overseas Hotels

SHANGHAI, Jan. 26 2020 /PRNewswire/ -- Further to the earlier statement on 23 January, Trip.com Group recently announced that it would expand the "Cancellation Guarantee" initiative to include hotels outside ofChina. Trip.com Group on 25 January offered cancellation waivers to about 30,000 globa...

2020-01-26 01:27 458

The World's First | GoMore Unveils a Revolutionary AI Coach for Weight Control with XTERRA, Dyaco

MUNICH, Jan. 25, 2020 /PRNewswire/ -- GoMore will debut its bleeding edge AI Coach system alongside XTERRA, Dyaco group at 2020 ISPO Munich Exhibition at Messe München exhibition ground,Germany from Jan 26-29, 2020. GoMore un...

2020-01-25 19:00 393

SunGen and Camber Announce U.S. Launch of Generic Version of Bentyl® (Dicyclomine) Injection

PRINCETON, New Jersey, Jan. 25, 2020 /PRNewswire/ -- SunGen Pharma, a privately held specialty pharmaceutical company which develops, contract manufactures, and sells pharmaceutical finished products, today announced the U.S. launch and commercial shipment of generic version of Bentyl® (Dicyclomi...

2020-01-25 06:16 532

Lipidor Announces Positive Topline Results of AKP01 Phase III Clinical Study Using Calcipotriol Spray Against Psoriasis

STOCKHOLM, Jan. 24, 2020 /PRNewswire/ -- Lipidor AB (Nasdaq First North: LIPI)  today reports positive topline results of its AKP01 Phase III clinical study, using calcipotriol spray against mild to moderate plaque psoriasis. The randomised 277-patient study achieved its primary endpoint demonstra...

2020-01-24 23:21 506

CStone announces first patient dosed in the global proof-of-concept study of CS1001 in combination with Bayer's regorafenib

SUZHOU, China, Jan. 24, 2020 /PRNewswire/ -- CStone Pharmaceuticals ("CStone" or the "Company", HKEX: 2616) recently announced that it has dosed the first patient inAustralia in a clinical trial of CS1001, an investigational PD-L1 inhibitor developed by CStone, in combination with regorafenib, an...

2020-01-24 14:26 567

Joint Action for World Leprosy Day 2020

TOKYO, Jan. 24, 2020 /PRNewswire/ -- Sasakawa Health Foundation has announced the start of its first-ever social media campaign with organizations of persons affected by leprosy. PerMaTa Indonesia, one of 17 organizations participating in the...

2020-01-24 10:00 399

CStone successfully hosted the first U.S. R&D Day in New York

* Among CStone's 15 cancer drug candidates, five candidates are in pivotal late-stage clinical development, with a total of 13 on-going registrational trials. * The Company has implemented its pipeline strategy for early-stage candidates and combination therapy. With an established clinical d...

2020-01-24 08:18 593

Cirque du Soleil Cancels Performances of "Cirque du Soleil The Land of Fantasy" in Hangzhou, China, Due to Coronavirus Outbreak

MONTREAL, Jan. 24, 2020 /PRNewswire/ -- Chinese officials have requested the temporary closing of all indoor activities with 100 or more people to stem the coronavirus outbreak. In the interest of safety for its audience members and employees, Cirque du Soleil will thus be cancelling all performa...

2020-01-24 07:46 396

CyberMDX Research Team Discovers Collection of GE Medical Device Vulnerabilities -- "MDhex"

CISA ICS has Issued an Advisory Containing 6 High-Severity CVEs for GE CARESCAPE, ApexPro, and Clinical Information Center (CIC) systems NEW YORK, Jan. 24, 2020 /PRNewswire/ -- A collection of six cybersecurity vulnerabilities has been discovered in a range of GE Healthcare devices popular ...

2020-01-24 02:48 468

Inovio Selected by CEPI to Develop Vaccine Against New Coronavirus

PLYMOUTH MEETING, Pa., Jan. 24, 2020 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced the Coalition for Epidemic Preparedness Innovations (CEPI) has awarded Inovio a grant of up to$9 million to develop a vaccine against the recently emerged strain of coronavirus (2019-nCo...

2020-01-24 00:26 948

Ascletis Received Approval of Clinical Trials in HBV Patients for ASC22, a Subcutaneously Administered PD-L1 Antibody

HANGZHOU and SHAOXING, China, Jan. 23, 2020 /PRNewswire/ -- Ascletis Pharma Inc. (Ascletis, 1672.HK) announces today the approval for ASC22 to conduct clinical trials in chronic hepatitis B patients inChina from China's National Medical Products Administration. ASC22 is a first-in-class, subcuta...

2020-01-23 09:52 601

New Clinical Trial Proves Allen Carr's Easyway to Stop Smoking Seminars Are at Least as Effective as the UK's Gold Standard NHS Stop Smoking Service

LONDON, Jan. 23, 2020 /PRNewswire/ -- The largest and most authoritative research trial of its kind has confirmed thatAllen Carr's Easyway (ACE) is now a clinically proven, highly effective drug-free alternative to nicotine patches, gum, and e-cigarettes and the study should pave the way for the ...

2020-01-23 08:01 485

Isagenix International Acquires Zija International

GILBERT, Arizona, Jan. 22, 2020 /PRNewswire/ -- Isagenix International, a global health and wellness company providing nutrition and lifestyle solutions, has announced its acquisition of Zija International, a well-established and respected direct selling company based inLehi, Utah, with a strong ...

2020-01-22 23:34 442

Hand Hygiene Market will Reach $1.98 Billion in the US and EU5 with High Adoption of Gamification

Artificial intelligence and machine learning to generate greater growth opportunities for hand hygiene companies, finds Frost & Sullivan SANTA CLARA, California, Jan. 22, 2020 /PRNewswire/ -- Due to the high cost of hospital stays, caregivers are increasingly shifting from hand wash and infectio...

2020-01-22 20:02 330

Argon Medical Announces the Commercial Launch of Two Inferior Vena Cava Filter Retrieval Kits

FRISCO, Texas, Jan. 22, 2020 /PRNewswire/ -- Argon Medical Devices, Inc. announced today the commercial launch of Single-Loop and Triple-Loop Retrieval Kits for sale in the U.S. The Single-Loop and Triple-Loop Retrieval Kits are intended for percutaneous removal of retrievable inferior vena cava ...

2020-01-22 18:49 349

Eddy Cojulun New Chief Sales Officer at Envirotainer

UPPLANDS VASBY, Sweden, Jan. 22, 2020 /PRNewswire/ --  Envirotainer, the global market leader in secure cold chain solutions for air transport of pharmaceuticals, today announced thatEddy Cojulun joined Envirotainer as the new Chief Sales Officer (CSO) inDecember 2019. In his new role Eddy will r...

2020-01-22 15:27 317

LABWorld China 2020 is Gearing Up

SHANGHAI, Jan. 22, 2020 /PRNewswire/ -- The National Medical Products Administration (NMPA) announced the first 45 key laboratories inJune 2019 and mentioned that the construction of national-level innovative key laboratories would play a guiding and demonstrated role in improving drug sci-tech ...

2020-01-22 11:37 354

Medical Director of Amaris B. Clinic Dr Ivan Puah Predicts 2020 Cosmetic Surgery Trend

SINGAPORE, Jan. 22, 2020 /PRNewswire/ -- Dr Ivan Puah, Medical Director of Amaris B. Clinic, who is accredited by the Ministry ofSingapore to perform surgical body sculpting treatments, has seen a plethora of diverse concerns from 25- to 65-year-old male and female patients inSingapore. 1. Rejuv...

2020-01-22 09:32 355

Animal Quarantine Service of Japan taking action over the possible introduction of ASF in the lead-up to the Chinese Lunar New Year

YOKOHAMA, Japan, Jan. 22, 2020 /PRNewswire/ -- Animal Quarantine Service of Japan (AQS), whose Headquarters are located in Yokohama City, Kanagawa Prefecture, will be strengthening preventive measures against the introduction of ASF (African Swine Fever), which is spreading acrossAsia, through me...

2020-01-22 09:00 393

Cognate BioServices closes Series B and completes acquisition of Cobra Biologics

MEMPHIS, Tennessee, Jan. 21, 2020 /PRNewswire/ -- Cognate BioServices, a leading contract development and manufacturing organization (CDMO) specialized in cell and cell-mediated gene therapy products today announced that it has completed the acquisition of Cobra Biologics, a leading CDMO speciali...

2020-01-22 08:04 419
12345 ... 240